Viewing Study NCT02021318


Ignite Creation Date: 2025-12-25 @ 4:54 AM
Ignite Modification Date: 2026-02-26 @ 12:03 PM
Study NCT ID: NCT02021318
Status: COMPLETED
Last Update Posted: 2024-11-14
First Post: 2013-12-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
Sponsor: Astellas Pharma Europe B.V.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1517-CL-0610
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View